Rodgers Brothers’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $791K | Hold |
1,609
| – | – | 0.09% | 150 |
|
|
2025
Q4 | $932K | Hold |
1,609
| – | – | 0.11% | 135 |
|
|
2025
Q3 | $780K | Sell |
1,609
-7,435
| -82% | -$3.46M | 0.1% | 155 |
|
|
2025
Q2 | $3.67M | Buy |
9,044
+6,925
| +327% | +$2.9M | 0.46% | 63 |
|
|
2025
Q1 | $1.05M | Hold |
2,119
| – | – | 0.14% | 129 |
|
|
2024
Q4 | $1.1M | Buy |
2,119
+37
| +2% | +$20.3K | 0.14% | 123 |
|
|
2024
Q3 | $1.29M | Sell |
2,082
-10
| -0.5% | -$5.92K | 0.16% | 118 |
|
|
2024
Q2 | $1.16M | Sell |
2,092
-150
| -7% | -$85.9K | 0.16% | 125 |
|
|
2024
Q1 | $1.3M | Hold |
2,242
| – | – | 0.18% | 119 |
|
|
2023
Q4 | $1.19M | Hold |
2,242
| – | – | 0.19% | 106 |
|
|
2023
Q3 | $1.13M | Sell |
2,242
-1
| -0% | -$533 | 0.19% | 108 |
|
|
2023
Q2 | $1.17M | Buy |
2,243
+76
| +4% | +$41K | 0.21% | 100 |
|
|
2023
Q1 | $1.25M | Buy |
2,167
+225
| +12% | +$127K | 0.24% | 99 |
|
|
2022
Q4 | $1.07M | Hold |
1,942
| – | – | 0.21% | 99 |
|
|
2022
Q3 | $985K | Hold |
1,942
| – | – | 0.21% | 115 |
|
|
2022
Q2 | $1.05M | Hold |
1,942
| – | – | 0.21% | 115 |
|
|
2022
Q1 | $1.15M | Buy |
1,942
+79
| +4% | +$45.4K | 0.21% | 111 |
|
|
2021
Q4 | $1.24M | Hold |
1,863
| – | – | 0.22% | 105 |
|
|
2021
Q3 | $1.06M | Hold |
1,863
| – | – | 0.21% | 112 |
|
|
2021
Q2 | $940K | Sell |
1,863
-50
| -3% | -$23.6K | 0.18% | 123 |
|
|
2021
Q1 | $873K | Hold |
1,913
| – | – | 0.18% | 121 |
|
|
2020
Q4 | $891K | Sell |
1,913
-100
| -5% | -$46.9K | 0.2% | 109 |
|
|
2020
Q3 | $889K | Hold |
2,013
| – | – | 0.23% | 107 |
|
|
2020
Q2 | $729K | Buy |
2,013
+400
| +25% | +$134K | 0.2% | 116 |
|
|
2020
Q1 | $457K | Hold |
1,613
| – | – | 0.15% | 132 |
|
|
2019
Q4 | $524K | Hold |
1,613
| – | – | 0.14% | 132 |
|
|
2019
Q3 | $470K | Hold |
1,613
| – | – | 0.13% | 140 |
|
|
2019
Q2 | $474K | Sell |
1,613
-25
| -2% | -$6.89K | 0.13% | 142 |
|
|
2019
Q1 | $448K | Buy |
1,638
+110
| +7% | +$27.4K | 0.13% | 141 |
|
|
2018
Q4 | $342K | Hold |
1,528
| – | – | 0.11% | 148 |
|
|
2018
Q3 | $373K | Hold |
1,528
| – | – | 0.11% | 153 |
|
|
2018
Q2 | $317K | Buy |
1,528
+100
| +7% | +$21.2K | 0.1% | 155 |
|
|
2018
Q1 | $295K | Buy |
+1,428
| New | +$300K | 0.1% | 157 |
|
Other funds holding TMO
VCM
Rodgers Brothers's TMO Position: Q1 2026 in Review
Rodgers Brothers held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 1,609 shares worth $791K. The position accounts for 0.09% of the portfolio, ranked #150.
Rodgers Brothers first reported a position in TMO in Q1 2018 and has held it in 33 quarters since. The position peaked at $3.67M in Q2 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Rodgers Brothers held 1,609 shares of Thermo Fisher Scientific worth $791K as of Q1 2026.
- Rodgers Brothers left its Thermo Fisher Scientific share count unchanged in Q1 2026.
- Thermo Fisher Scientific made up 0.09% of Rodgers Brothers's portfolio in Q1 2026, its #150 holding.
- Rodgers Brothers first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 33 quarters since.
- Rodgers Brothers's Thermo Fisher Scientific position peaked at $3.67M in Q2 2025.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Rodgers Brothers's 13F filing for Q1 2026, filed 14 May 2026.